Target Price | HKD34.31 |
Price | HKD27.00 |
Potential |
27.08%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target JD Health International 2025 .
The average JD Health International target price is HKD34.31.
This is
27.08%
register free of charge
HKD42.89
58.87%
register free of charge
HKD21.96
18.68%
register free of charge
|
|
A rating was issued by 17 analysts: 14 Analysts recommend JD Health International to buy, 1 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2025 of
27.08%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion HKD | 59.15 | 62.01 |
8.84% | 4.84% | |
EBITDA Margin | 1.60% | 3.17% |
16,955.58% | 97.70% | |
Net Margin | 4.10% | 5.75% |
398.79% | 40.31% |
15 Analysts have issued a sales forecast JD Health International 2024 . The average JD Health International sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an JD Health International EBITDA forecast 2024. The average JD Health International EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 JD Health International Analysts have issued a net profit forecast 2024. The average JD Health International net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.76 | 1.12 |
442.86% | 47.37% | |
P/E | 23.78 | |
EV/Sales | 0.55 |
7 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the JD Health International stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
JD Health International...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.